Natural course of voiding function in patients with human T-cell lymphotrophic virus type 1-associated myelopathy

Journal of the Neurological Sciences

Volumn 217, Issue 1, 2004, Pages 3-6

  Mori, Ken Ichi ^a   Noguchi, Mitsuru ^a   Matsuo, Manabu ^a   Nomata, Koichiro ^a   Nakamura, Tatsufumi ^a   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

HAM; HTLV I; Neurogenic bladder

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BLADDER FUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; FEMALE; GENDER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INTERMITTENT CATHETERIZATION; MALE; MEDICAL SPECIALIST; MICTURITION; MICTURITION DISORDER; ONSET AGE; PATIENT; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RNA VIRUS INFECTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SYMPTOMATOLOGY; TROPICAL DISEASE;

EID: 0346219386     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.08.004     Document Type: Article

References (14)

1. Gessian A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A. Antibodies to human T-lymphotrophic virus type-I in patients with tropical spastic paraparesis. Lancet. ii:1985;407-409.
2. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A. HTLV-I associated myelopathy: a new clinical entity. Lancet. 1(8488):1986 (May 3);1031-1032.
3. Roman G.C., Osame M. Identity of HTLV-1-assosiated tropical spastic paraparesis and HTLV-1-assosiated myelopathy. Lancet. 1(8586):1988 (Mar. 19);651.
4. Vernant J.C., Buisson G., Magdeleine J., De Thore J., Jouannelle A., Neisson-Vernant C.et al. T-lymphocyte alveolitis, tropical spastic paresis, and sjögren syndrome. Lancet. 1(8578):1988 (Jan. 23);177.
5. Mochizuki M., Watanabe T., Yamaguchi K., Yoshimura K., Nakashima S., Shirao M.et al. Uveitis associated with human T-cell lymphotropic virus type I. Am. J. Ophthalmol. 114:1992;123-129.
6. Eguchi K., Nakamura T., Mine M., Ida H., Kawasaki A., Migita K.et al. HTLV-1 associated arthritis: characteristics of an HTLV-1 virus infected T cell line from synovial fluid. Ann. Rheum. Dis. 51:1992;673-677.
7. Higuchi I., Montemayer E.S., Izumo S., Inose M., Osame M. Immunohistochemical characteristics of polymyositis in patients with HTLV-1-associated myelopathy and HTLV-1 carriers. Muscle Nerve. 16:1993;472-476.
8. Fukuzawa T., Hamada T., Hamada K., Yanagihara T., Tashiro K., Morikawa F. HTLV-1-associated myelopathy combined with chronic thyroiditis. J. Intern. Med. 230:1991;89-90.
9. Kanazawa H., Ijichi S., Eiraku N., Igakura T., Higuchi I., Nakagawa M.et al. Behçet's disease and sjögren syndrome in a patient with HTLV-1-associated myelopathy. J. Neurol. Sci. 119:1993;121-122.
10. Nomata K., Nakamura T., Suzu H., Yushita Y., Kanetake H., Sawada T.et al. Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis. Jpn. J. Cancer Res. 83:1992;601-608.
11. Matsushita K., Arima N., Ohtsubo H., Fujiwara H., Arimura K., Kukita T. et al. Poor response to predonisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection. Am. J. Hematol. 71:2002;20-23.
12. Hollsberg P., Hafler D.A. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesisi of disease induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1993;1173-1182.
13. Imamura A., Kitagawa T., Ohi Y., Osame M. Clinical manifestation of human T-cell lymphotrophic virus type-I-associated myelopathy and vesicopathy. Urol. Int. 46:1991;149-153.
14. Nakagawa M., Izumo S., Ijichi S., Kubota H., Arimura K., Kawabata M.et al. HTLV-1-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J. Neurovirol. 1:1995;50-61.